The Building is currently 50% leased to Xencor, a publicly traded biopharmaceutical company, focused on the discovery and development of monoclonal antibody therapeutics to treat autoimmune, allergic diseases and cancer. Xencor recently announced the expansion and relocation of their company headquarters from Monrovia, California to nearby Pasadena area, whereby they have vacated the 111 W. Lemon Building. Xencor’s lease on the second floor expired December 31, 2025. Both Landlord and Tenant are willing to entertain an early lease termination in the event a Prospective Tenant is interested in leasing the entirety of the Building.